SCHEMBL5041999

SCHEMBL5041999

COC(C(=O)O)c1ccc(N(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
GAA P10253 4/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
SLC2A1 P11166 1/20 0.46
MAPT P10636 3/20 0.45
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4187065 0.84 ALDH1A1 (0.47) ALDH1A1GAAL3MBTL1SLC2A1MAPT
SCHEMBL1579147 0.80 ALDH1A1 (0.47) ALDH1A1GAAL3MBTL1SLC2A1MAPT
SCHEMBL1578781 0.80 GAA (0.48) ALDH1A1GAAL3MBTL1SLC2A1MAPT
SCHEMBL5040593 0.79 SRC (0.46) ALDH1A1GAAL3MBTL1MAPTALOX15
SCHEMBL29069338 0.79 KEAP1 (0.41) ALDH1A1GAAL3MBTL1KDM4ETSHR
SCHEMBL24327745 0.79 KEAP1 (0.55) ALDH1A1GAAL3MBTL1RAB9ASMN1; SMN2
SCHEMBL28194345 0.79 CYP2C9 (0.46) ALDH1A1GAAHPGDKDM4ERAB9A
SCHEMBL11193156 0.78 ALDH1A1 (0.49) ALDH1A1GAAL3MBTL1MAPTHPGD
SCHEMBL103235 0.78 ALDH1A1 (0.54) ALDH1A1GAAL3MBTL1KDM4EKMT2A
SCHEMBL155984 0.78 ALDH1A1 (0.54) ALDH1A1GAAL3MBTL1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 ALDH1A1 519/4885GAA 1312/4885L3MBTL1 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.